Navigation Links
Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
Date:10/19/2007

on to consolidate certain

operations and close our facility in Syracuse, NY has impacted the

shipment and production timing of a limited number of orders for

surgical needles.

- Our original full year 2007 outlook for sales revenue derived from

certain new product lines was $10 million to $30 million. At the

present time we expect to begin generating more substantial revenue

from these sources starting in 2008, rather than in the second half

of 2007 as originally expected, as a result of several factors,

including:

- Longer regulatory review times than originally expected, primarily

for our Vascular Wrap(TM) product candidate in the European Union

(EU). While we completed our EU clinical trial and submitted all

regulatory filings as planned, review and approval timelines are

entirely at the discretion of the regulatory body in the EU, and

are not specifically mandated. We had originally expected this

product candidate would be approved for sale by the third quarter

of 2007. We now expect this product candidate, should it receive

EU regulatory approval, to be available for sale in first half of

2008;

- An initial "time to first order" of 9 to 12 months, as opposed to

the originally forecasted 3 to 6 months, for our Quill(TM) SRS

product line in the majority of customer accounts. Importantly, we

continue to remain on track to sign up approximately 275 customer

accounts by year-end. As of October 2007, we had signed

approximately 230 Quill(TM) SRS customer accounts, including

67 hospitals, 89 clinics and 74 physician offices, as compared to

only a small number of ordering accounts and fewer than 10

hospitals as of June 2007. As a result of p
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 02, 2014 IAL is pleased ... of its report on the markets for rigid ... examines the developments encountered in the global market ... , Full Report With TOC @ ... trends driving the demand. The study presents production ...
(Date:10/2/2014)... MO (PRWEB) October 02, 2014 Permian ... business in the St. Louis, Missouri, area on October ... has become a leading plastic injection molder in the ... machines and is a supplier to many Fortune 500 ... customer support every step of the way, from concept ...
(Date:10/2/2014)... de 2014 Laborie Medical Technologies, Inc. ("LABORIE"), ... ha completado la adquisición de Unisensor AG y Unisensor ... sede central sita en Wiesendangen, Suiza, y lleva a ... New Hampshire . Unisensor está especializada en el ... para evaluar la presión y valores de pH para ...
(Date:10/2/2014)... -- SIRO Clinpharm, an award-winning Clinical Research ... Annual Conference of the Society for Clinical Data Management ... where they were invited to speak at three sessions. ... to support fraud detection, ,clinical data management,s role in ... together as virtual and integrated teams,. The award-winning streak ...
Breaking Biology Technology:Global Overview of the Spray Polyurethane Foam (SPF) & One Component Foam (OCF) : Industry Analysis, Size, Share, Trends And Forecast Research Report by Researchmoz 2Permian Plastics LLC Celebrates 20 Years As Leading Manufacturer of Plastic Molds 2LABORIE adquiere Unisensor AG y Unisensor USA, Inc. 2SIRO Clinpharm Showcases Biometrics Capabilities at the SCDM 2014 Annual Conference in Las Vegas 2
... 15 MannKind,Corporation (Nasdaq: MNKD ), focused on ... today that it,will present at the UBS Global Life ... (ET) at the Grand Hyatt in New York., ... web cast of the,presentation in the Investor Relations section ...
... Join as Company Enters Commercialization Phase, NAPLES, ... TO ETHANOL(TM), the most advanced third generation biofuels,technology, ... with the,appointments Greg Schlicht as Senior Vice President ... as Senior Program Manager., Mr. Schlicht will ...
... Sept. 15 Insmed Inc. (Nasdaq:,INSM) a developer ... Allan, Ph.D., CEO of Insmed, will present at ... will be discussing,the Company,s perspective on the potential ... will also Chair a panel on this topic ...
Cached Biology Technology:Algenol Biofuels Further Strengthens Team With Key Appointments 2Insmed to Present at Biosimilars 2008 Conference 2
(Date:9/30/2014)... 2014--Sea monkeys have captured the popular attention of both ... life cycle -- sold as dehydrated eggs, these tiny ... more than a tank of salt water. , ... other zooplankton, brine shrimp vertically migrate in large groups ... the surface at night and retreating deeper during the ...
(Date:9/30/2014)... team of environmental scientists and engineers, led by ... a three-year, $5.25 million grant from the U.S. ... Research to make a direct positive impact on ... and disposal of radioactive contaminants. , "Understanding the ... dealing with environmental aspects of nuclear technologies is ...
(Date:9/30/2014)... can live in almost any aquatic environment on Earth, ... many species are pushed to the limit. The amount ... prove critical for how different species cope in the ... University of Gothenburg, published in the scientific journal ... change continues apace thanks to increasing levels of greenhouse ...
Breaking Biology News(10 mins):Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2Researchers get $5.25 million to advance nuclear technologies in South Carolina 2Shape up quickly -- applies to fish, too! 2
... the Bellvitge Biomedical Research Institute (IDIBELL) at the ... into how the IDPN nitrile causes neurological syndromes ... (ALS), a severe neuromuscular degenerative disease. The study, ... in Neuropathology and Applied Neurobiology journal. ...
... to dust off the garden tables and chairs. But garden furniture ... covered with a slimy film of algae, moss, bacteria and fungi ... hoping that they can solve this problem by incorporating titanium dioxide ... adding a little bit of sunlight. When these titanium dioxide molecules ...
... German . Zebrafish share most organ systems ... the causes of human diseases like cancer or heart diseases. ... With the European Zebrafish Resource Center (EZRC), Karlsruhe Institute of ... such lines in Europe. The EZRC is funded jointly by ...
Cached Biology News:Poisoning from industrial compounds can cause similar effects to ALS 2Cleaning with sunlight 2Zebrafish -- the stars of biomedicine 2
Human SEAP ORF, provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
... of purified RNA samples., , This product ... aqueous RNA samples that have been pre-purified ... silica, oligo dT etc or other kits. ... necessary components for the stabilization of nanogram ...
... These 2800mL wide mouth PYREX Fernbach-style culture ... center of the flask bottom to achieve ... triple baffled flasks have a Delong-style 38mm ... steel closures. For plastic closures see Nos. ...
... template is designed to allow neomycin/kanamycin selection ... FRT-PGK-gb2-neo-FRT template encodes the neomycin/kanamycin resistance gene ... expression of kanamycin resistance in E.coli ... expression of neomycin resistance in mammalian cells. ...
Biology Products: